Patent Recognition For AI-Based Predictive Health Diagnostics.

06 Apr 2026 --
0 Comments

1. Understanding AI-Based Predictive Health Diagnostics

AI-based predictive health diagnostics refers to systems that:

Analyze patient data (labs, imaging, genomics, EHRs) using AI/ML algorithms.
Predict health risks, disease onset, or treatment outcomes.
Provide decision support for clinicians.

From a patent perspective, key aspects include:

Patentable Subject Matter – Is software-based AI applied to health diagnostics patentable?
Novelty & Inventive Step – Is the AI algorithm or method new and non-obvious compared to prior art?
Utility / Industrial Application – Does it provide a practical medical benefit, such as predicting disease with higher accuracy?

Patent offices generally allow software patents if they have a specific technical effect. In medicine, this is often improved diagnostic accuracy, faster predictions, or novel data processing methods.

2. Challenges in Patent Recognition

Abstract Ideas – Courts are wary of patents claiming pure algorithms or mathematical methods. The AI must be tied to specific medical applications.
Medical Ethics & Data Use – AI that predicts health risks must respect ethical and privacy standards, but patent law usually focuses on invention, not ethics.
Obviousness – Simply applying known AI models (e.g., neural networks) to medical data may be considered obvious without inventive technical modifications.

3. Relevant Case Laws on AI, Diagnostics, and Patentability

Here are more than five landmark cases, explained in detail.

Case 1: Mayo Collaborative Services v. Prometheus Laboratories (2012, US Supreme Court)

Facts: Prometheus patented a method for optimizing drug dosage based on metabolite levels in patients.
Issue: Is a method that measures a natural phenomenon (drug metabolite levels) patentable?
Holding: Supreme Court ruled no; the method was based on a natural law and routine data gathering, so it was unpatentable.
Relevance to AI Diagnostics: Predictive AI must not merely correlate patient biomarkers with disease; it must involve novel algorithms or technical processing steps that improve diagnostics.

Case 2: Alice Corp. v. CLS Bank International (2014, US Supreme Court)

Facts: Software patent for financial transaction risk mitigation.
Issue: Are computer-implemented abstract ideas patentable?
Holding: No; abstract ideas implemented on a generic computer are not patentable.
Relevance: AI health diagnostics must show technical implementation details—e.g., new neural network architectures, improved image processing for radiology—not just “AI predicts disease.”

Case 3: Diamond v. Diehr (1981, US Supreme Court)

Facts: Patent for curing synthetic rubber using a computer-calculated formula.
Holding: Patentable because it involved a technical process improving manufacturing.
Relevance: AI diagnostic methods can be patentable if they produce a technical effect, like improved disease prediction accuracy or faster diagnostic processing.

Case 4: Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals (2018, US Court of Appeals for the Federal Circuit)

Facts: Patent involved dosing schizophrenia medication based on genetic testing.
Holding: The Court upheld the patent as medically useful and non-obvious, linking genetic data to specific treatment decisions.
Relevance: AI that predicts personalized treatment based on patient data can qualify for patent protection if it applies specific data processing steps to achieve measurable medical outcomes.

Case 5: Enfish, LLC v. Microsoft Corp. (2016, US Federal Circuit)

Facts: Self-referential database for faster data retrieval.
Holding: Claims are patentable if they improve computer functionality rather than merely applying an abstract idea.
Relevance: AI diagnostics can be patentable if the AI improves data processing, speed, or accuracy—not just predicting disease using generic models.

Case 6: Therasense Inc. v. Becton Dickinson & Co. (2011, US Federal Circuit)

Facts: Dispute over patent claims for medical devices detecting biomarkers.
Holding: Reinforced strict standards for proving patent invalidity based on prior art.
Relevance: Properly drafted AI diagnostic patents can be robustly defended if novel technical features and datasets are documented.

Case 7: European Patent Office – T 0250/03 (EPO, 2005)

Facts: Patent application for a medical diagnostic software system.
Holding: Patent granted because software produced a technical effect on data processing.
Relevance: In Europe, AI predictive diagnostics can be patented if they alter the technical functioning of the system, like processing imaging data in a new way to detect tumors.

4. Key Lessons for Patent Recognition

Tie AI to Technical Effect: Claims must focus on how AI technically improves diagnostics, not just predicts disease.
Specific Implementation Matters: Include unique algorithms, model architectures, or data preprocessing steps.
Demonstrate Utility: Show measurable medical benefits—accuracy, speed, or treatment recommendation improvements.
Avoid Pure Abstraction: Generic AI or statistical correlations alone are not patentable (Mayo, Alice).
Document Algorithms and Workflows: Courts favor well-documented, specific steps over high-level claims.